Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.

Front Immunol · 2019 · PMC6593303 · PMID 31275298

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a Swiss case-controlled study of 23 diabetic BP patients and 170 diabetic controls DPP-4i use was more frequent in the diabetic BP patients than the controls (39.1 and 33.5%, respectively) although the difference did not reach statistical significance ( 50 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.